RecruitingPhase 4NCT06763731
Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Sponsor
National Taiwan University Hospital
Enrollment
150 participants
Start Date
May 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.
Eligibility
Min Age: 20 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Systane COMPLETE for people with ophthalmology. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 85 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGSystane COMPLETE
Preop dry eye management using Systane COMPLETE can help to optimize the ocular surface.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06763731
Related Trials
An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction
NCT068744521 location
Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
NCT068863731 location
Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.
NCT071786001 location